France· FR:61564058
MELAXIB 3,50 g/4,29 g/2,14 g pour 10 g, pâte orale en sachet
A medicinal product containing vaseline + lactulose + paraffine liquide, registered in France by BIOCODEX.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- VASELINE + LACTULOSE + PARAFFINE LIQUIDE
- Manufacturer
- BIOCODEX
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
- cip1334009222455466 sachet(s) polytéréphtalate (PET) aluminium polyéthylène basse densité (PEBD) de 10 g
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/85d05d25-8c66-4f8d-95db-1cc8a5a6c82a GET /v1/drugs/85d05d25-8c66-4f8d-95db-1cc8a5a6c82a?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "61564058",
"date_amm": "2012-04-19",
"type_amm": "Procédure nationale",
"numero_ue": null,
"substance": "VASELINE + LACTULOSE + PARAFFINE LIQUIDE",
"statut_amm": "Autorisation active",
"statut_bdm": "Warning disponibilité",
"forme_pharmaceutique": "pâte",
"voies_administration": "orale",
"etat_commercialisation": "Non commercialisée",
"surveillance_renforcee": "Non"
}See everything about vaseline + lactulose + paraffine liquide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.